Skip to main content
. 2024 Sep 25;44(12):3087–3092. doi: 10.1007/s00296-024-05724-z

Fig. 2.

Fig. 2

A/B Serum levels of Anti-Muellerian hormone (AMH) in patients with systemic sclerosis receiving different therapies (myophenolate mofetil [MMF], glucocorticoids [GC] as high as prednisone ≤ 5mg per day, azathioprine [AZA], and methotrexate [MTX]) compared to healthy controls (HC)) (2A). In addition patients with or without bosentan showed a significant difference (2B)